Achieve life sciences announces cytisinicline phase 3 orca-3 trial publication on smoking cessation in jama internal medicine

Orca-3 demonstrated a significant increase in quitting and reduction in nicotine cravings for cytisinicline-treated participants compared to placebo

ACHV Ratings Summary

ACHV Quant Ranking